Linked Life Data

17275167

Source:http://linkedlifedata.com/resource/pubmed/id/17275167

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-4-30
pubmed:abstractText
Positron emission tomography (PET) provides unique insights into molecular pathways of diseases. PET using [F-18]-fluorodeoxyglucose (FDG) has gained increasing acceptance for the diagnosis, staging, and treatment monitoring of various tumour types. The aim of this review is to provide an update on the current status of molecular PET and PET/CT imaging in urological malignancies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0302-2838
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1511-20; discussion 1520-1
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Molecular positron emission tomography and PET/CT imaging in urological malignancies.
pubmed:affiliation
Department of Urology, Barts and the London School of Medicine, Queen Mary, University of London, London, UK.
pubmed:publicationType
Journal Article, Review